Trade Summary

5 days ago, ADAR1 Capital Management, LLC, serving as 10% owner Owner at NextCure, Inc. (NXTC), purchased 329,153 shares at $4.93 per share, for a total transaction value of $1,624,120.50. Following this transaction, ADAR1 Capital Management, LLC now holds 722,419 shares of NXTC.

This purchase represents a 83.70% increase in ADAR1 Capital Management, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 30, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 3, 2026 at 5:53 PM ET, 4 days after the trade was made.

NextCure, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.